4 (a) G. Legler, in Iminosugars as Glycosidase Inhibitors: Nojirimycin and
Beyond, ed. A. E. Stu¨tz, Wiley-VCH, Weinheim, 1999, p. 50; (b)
N. Asano, R. J. Nash, R. J. Molyneux and G. W. J. Fleet, Tetrahedron:
Asymmetry, 2000, 11, 1645.
5 G. W. J. Fleet, A. Karpas, R. A. Dwek, L. E. Fellows, A. S. Tyms,
S. Petursson, S. K. Namgoong, N. G. Ramsden, P. W. Smith, J. C. Son,
F. X. Wilson, D. R. Witty, G. S. Jacob and T. W. Rademacher, FEBS
Lett., 1988, 237, 128.
From the stereochemical point of view two new stereogenic
centers, C4 and C5, are generated sequentially from the starting
4-formyl-b-lactam. Stereocenter C4 is formed first as a result of the
expansion process of the b-lactam nucleus involving cleavage of
the C3–C4 bond. The fact that compounds 2 and 5 have the same
anti-C3–C4 relative stereochemistry points to a concerted mechan-
ism for this process. Intermediate chelate 6 would be responsible
for the observed stereochemistry at C4. Regarding the C5
stereocenter, its generation cannot be accounted for by taking
into consideration steric effects. In agreement with previous reports
on the Lewis acid-promoted syn-addition of tin and silicon
nucleophiles to N-acyliminium ions controlled by an adjacent
OTBS group,20 the stereochemical outcome may be ruled by the
Cieplak-type stereoelectronic effect.21
6 For an excellent review on their use as building blocks for the synthesis
of biologically active compounds, see: C. Na´jera and M. Yus,
Tetrahedron: Asymmetry, 1999, 10, 2245.
7 More specifically, 5-cyano-3,4-dihydroxypyrrolidin-2-ones have been
used as advanced precursors for the synthesis of 3,4-dihydroxyglutamic
acids, a natural glutamic acid derivative isolated from the seeds of
Lepidum sativum and the leaves of Rheum rhaponticum. See, for
example: (a) M. Oba, Sh. Koguchi and K. Nishiyama, Tetrahedron,
2004, 60, 8089; (b) M. Oba, Sh. Koguchi and K. Nishiyama,
Tetrahedron, 2002, 58, 9359; (c) N. Langlois, Tetrahedron Lett., 1999,
40, 8801.
8 For recent references to the asymmetric synthesis of pyrrolidines, see, for
example: (a) J. Carreras, A. Avenoza, J. H. Busto and J. M. Peregrina,
Org. Lett., 2007, 9, 1235; (b) J. Ichikawa, G. Lapointe and Y. Iwai,
Chem. Commun., 2007, 2698; (c) G. Pandey, P. Banerjee and S. R. Gadre,
Chem. Rev., 2006, 106, 4484; (d) J.-L Vasse, A. Joosten, C. Denhez and
J. Szymoniak, Org. Lett., 2005, 7, 4887.
9 For a very recent review, see: B. Alcaide, P. Almendros and
C. Aragoncillo, Chem. Rev., 2007, 107, 4437.
10 For a review on the selective bond cleavage of the b-lactam nucleus, see:
B. Alcaide and P. Almendros, Synlett, 2002, 381.
11 See, for example: B. Alcaide, P. Almendros, G. Cabrero and M. P. Ruiz,
Chem. Commun., 2007, 4788.
12 As far as we know, the only related iodo-catalyzed rearrangement of
monocyclic b-lactams, namely the conversion of 3-(acylamino)-l,4-
diphenyl-2-azetidinones to 3-(acylamino)-l,2-diphenyl-6-imidazoles, was
reported by Bird, while the rearrangement of penicillin to penillonic acid
is known to occur in the bicyclic series. See, for instance: (a) C. W. Bird
and J. D. Twibell, J. Chem. Soc. C, 1971, 3155; (b) C. W. Bird,
Tetrahedron, 1966, 22, 2489.
13 For other acid-catalyzed C3–C4 bond cleavage of the b-lactam nucleus,
see: B. Alcaide, Y. Mart´ın-Cantalejo, J. Rodr´ıguez-Lo´pez and
M. A. Sierra, J. Org. Chem., 1993, 58, 4767.
14 B. Alcaide and P. Almendros, Chem. Soc. Rev., 2001, 30, 226.
15 See, for example: (a) J. Sun, Y. Dong, L. Cao, X. Wang, Sh. Wang and
Y. Hu, J. Org. Chem., 2004, 69, 8932; (b) P. Phukan, J. Org. Chem.,
2004, 69, 4005; (c) R. A. Periana, O. Mirinov, D. J. Taube and
S. Gamble, Chem. Commun., 2002, 2376; (d) J. S. Yadav, B. V. S. Reddy,
C. V. Rao, P. K. Chand and A. R. Prasad, Synlett, 2001, 1638.
16 J. S. Yadav, B. V. S. Reddy, M. Sridhar Reddy and A. R. Prasad,
Tetrahedron Lett., 2002, 43, 9703.
In conclusion, a novel iodo-catalyzed C3–C4 bond breakage of
the b-lactam skeleton in 4-oxoazetidine-2-carbaldehydes 1 has
been uncovered and this relies upon appropriate substitution and
stereochemistry at C3. In addition, a new, direct method for the
diastereoselective preparation of optically pure protected 5-cyano-
3,4-dihydroxypyrrolidin-2-ones 2 and 5 is described. Studies
concerning the scope and generality of this methodology, as well
as mechanistic implications are underway in our laboratory, and
further details will be reported in due course.
Support for this work by the DGI-MEC (Project CTQ2006-
10292) and CAM-UCM (Grant GR69/06) are gratefully acknowl-
edged. G. C. thanks the MEC for a predoctoral grant.
Notes and references
{ Representative experimental procedure for the b-lactam ring expansion
reaction: Synthesis of the pyrrolidin-2-one derivative 2a. A solution of
TBSCN (271 mg, 1.92 mmol) in acetonitrile (4.3 mL) was added dropwise
to a stirred solution of the 4-oxoazetidine-2-carbaldehyde 1a (300 mg,
1.28 mmol) and molecular iodine (32 mg, 0.13 mmol) in acetonitrile
(4.3 mL) at RT and under argon. The reaction mixture was stirred until
disappearance of starting material (TLC). Then, brine was added and the
resulting mixture was extracted with DCM. The organic layer was dried
and the solvent was removed under reduced pressure. Analytically pure
adduct 2a (375 mg, 78%) was obtained after purification by flash
chromatography on silica gel using a hexanes–ethyl acetate (5 : 1) mixture.
17 L. Royer, S. K. De and R. A. Gibbs, Tetrahedron Lett., 2005, 46, 4595.
18 Enantiopure spiranic or 3-substituted 3-alkoxy-b-lactam aldehydes 4a
and 4b were prepared from (S)-4-[(S)-2,2-dimethyl-1,3-dioxolan-4-yl]-1-
(4-methoxyphenyl)azetidine-2,3-dione via metal-mediated Barbier-type
carbonyl-addition reactions in aqueous media followed by functionaliza-
tion reactions, as we recently described. See: B. Alcaide, P. Almendros
and M. C. Redondo, Eur. J. Org. Chem., 2007, 3707.
19 Optically pure trans-4-oxoazetidine-2-carbaldehyde (+)-epim-1a was
prepared as reported, see: D. R. Wagle, C. Garai, J. Chiang, M. G.
Monteleone, B. E. Kurys, T. W. Strohmeyer, V. R. Hedge, M. S.
Manhas and A. K. Bose, J. Org. Chem., 1988, 53, 4227.
1 (a) J. W. Daly, T. F. Spande and H. M. Garraffo, J. Nat. Prod., 2005,
68, 1556; (b) D. O’Hagan, Nat. Prod. Rep., 2000, 17, 435 and references
therein; (c) J. W. Daly, H. M. Garraffo and T. F. Spende, in Alkaloids:
Chemical and Biological Perspectives, ed. S. W. Pelletier, Pergamon,
New York, 1999, vol. 13, ch. 1.
2 Organocatalysts: for recent reviews, see: (a) S. Sulcer-Mosse´ and
A. Alexakis, Chem. Commun., 2007, 3123; (b) C. Palomo and H. Mielgo,
Angew. Chem., Int. Ed., 2006, 45, 7876; (c) M. Marigo and A. Jorgensen,
Chem. Commun., 2006, 2001; Chiral auxiliaries or ligands: (d) B. H. Kim,
H. B. Lee, J. K. Hwang and Y. G. Kim, Tetrahedron: Asymmetry, 2005,
16, 1215; (e) F. Fache, E. Schultz, M. L. Tomasino and M. Lemaire,
Chem. Rev., 2000, 100, 2159; (f) J. K. Whitesell, Chem. Rev., 1989, 89,
1581.
20 For similar stereocontrolled reactions with 3 or 4-substituted
N-acylpyrrolidinium ions, see: M. Thaning and L.-G. Wistrand, Acta
Chem. Scand., 1989, 43, 290.
3 J. R. Behling, A. L. Campbell, K. A. Babiak, J. S. Ng, J. Medich,
P. Farid and G. W. J. Fleet, Tetrahedron, 1993, 49, 3359.
21 A. S. Cieplak, J. Am. Chem. Soc., 1981, 103, 4540.
This journal is ß The Royal Society of Chemistry 2008
Chem. Commun., 2008, 615–617 | 617